Category: Mergers & AcquisitionsSyndicate content

Danaher becomes dental giant with $2.1B Nobel Biocare buy

September 15, 2014 by Arezu Sarvestani

The $2.14 billion acquisition of Nobel Biocare will turn Danaher into the largest dental implants provider in the world.

Danaher becomes dental giant with $2.1B Nobel Biocare buy

Second suitor ceded early to Zimmer in chase for Biomet

September 12, 2014 by Brad Perriello

A 2nd suitor for orthopedic device maker Biomet ceded the field early to Zimmer, regulatory filings show, but Biomet held out for better terms from its cross-town rival.

Second suitor ceded early to Zimmer in chase for Biomet

Kimberly-Clark readies Halyard Health medical device spinout

September 11, 2014 by Brad Perriello

Halyard Health, the publicly traded, $1.6 billion spinout of Kimberly-Clark's medical device business, is slated to go live in November, soon-to-be COO Chris Lowery tells MassDevice.com.

Kimberly-Clark readies Halyard Health medical device spinout

Baxter names its pharma spinout: Baxalta

September 11, 2014 by Arezu Sarvestani

Baxter's has 'high' hopes for its coming Baxalta spinout, which will get a full visual work-up before the company goes live mid-2015.

Baxter names its pharma spinout: Baxalta

Baxter (NYSE:BAX) crept a little closer to spinning out its biopharmaceuticals division into an independent entity by giving the company a name: Baxalta.

Japan probes Biomet-Zimmer merger

September 10, 2014 by Brad Perriello

Japanese regulators are the latest to probe the pending merger of Biomet and Zimmer to make sure it meets anti-trust muster.

Japan probes Biomet-Zimmer merger

Remote monitoring companies join forces for cardiac patients

September 10, 2014 by Arezu Sarvestani

Preventice and eCardio agree to an alliance, combining their remote patient monitoring platforms and their sales teams under a new holding company.

Remote monitoring companies joing forces for cardiac patients

Remote patient care company Preventice and remote cardiac monitoring devices maker eCardio Diagnostics announced this week that they would join forces and merge sales operations under a new holding company, Preventice Inc.

The new company combines Preventice's commercially available wireless remote cardiac monitoring systems with eCardio's national sales force and patient monitoring center.

Allergan caves to shareholder meeting after Valeant, Ackman rally support

September 9, 2014 by Arezu Sarvestani

Allergan confirmed late last week that it would call the shareholder meeting demanded by unsolicited buyers Valeant Pharmaceuticals and activist investor William Ackman.

Allergan caves to shareholder meeting after Valeant, Ackman rally support
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp